Cargando…
Assessing liver fibrosis in all patients with type 2 diabetes and fatty liver disease: It's time to act now
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077729/ https://www.ncbi.nlm.nih.gov/pubmed/35119217 http://dx.doi.org/10.1111/jdi.13765 |
| _version_ | 1784702174772592640 |
|---|---|
| author | Lee, Chi Ho Lui, David T W Lam, Karen S L |
| author_facet | Lee, Chi Ho Lui, David T W Lam, Karen S L |
| author_sort | Lee, Chi Ho |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9077729 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90777292022-05-13 Assessing liver fibrosis in all patients with type 2 diabetes and fatty liver disease: It's time to act now Lee, Chi Ho Lui, David T W Lam, Karen S L J Diabetes Investig Commentary John Wiley and Sons Inc. 2022-02-16 2022-05 /pmc/articles/PMC9077729/ /pubmed/35119217 http://dx.doi.org/10.1111/jdi.13765 Text en © 2022 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Commentary Lee, Chi Ho Lui, David T W Lam, Karen S L Assessing liver fibrosis in all patients with type 2 diabetes and fatty liver disease: It's time to act now |
| title | Assessing liver fibrosis in all patients with type 2 diabetes and fatty liver disease: It's time to act now |
| title_full | Assessing liver fibrosis in all patients with type 2 diabetes and fatty liver disease: It's time to act now |
| title_fullStr | Assessing liver fibrosis in all patients with type 2 diabetes and fatty liver disease: It's time to act now |
| title_full_unstemmed | Assessing liver fibrosis in all patients with type 2 diabetes and fatty liver disease: It's time to act now |
| title_short | Assessing liver fibrosis in all patients with type 2 diabetes and fatty liver disease: It's time to act now |
| title_sort | assessing liver fibrosis in all patients with type 2 diabetes and fatty liver disease: it's time to act now |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077729/ https://www.ncbi.nlm.nih.gov/pubmed/35119217 http://dx.doi.org/10.1111/jdi.13765 |
| work_keys_str_mv | AT leechiho assessingliverfibrosisinallpatientswithtype2diabetesandfattyliverdiseaseitstimetoactnow AT luidavidtw assessingliverfibrosisinallpatientswithtype2diabetesandfattyliverdiseaseitstimetoactnow AT lamkarensl assessingliverfibrosisinallpatientswithtype2diabetesandfattyliverdiseaseitstimetoactnow |